Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Integrative "omic" analysis for tamoxifen sensitivity through cell based models.

PloS one - 1 Jan 2014

Weng Liming, Ziliak Dana, Lacroix Bonnie, Geeleher Paul, Huang R Stephanie

Abstract excerpt

It has long been observed that tamoxifen sensitivity varies among breast cancer patients. Further, ethnic differences of tamoxifen therapy between Caucasian and African American have also been reported. Since most studies have been focused on Caucasian people, we sought to comprehensively evaluat...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Black or African American
Share to Black People
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Line, Tumor

Share to HapMap Project

Share to MicroRNAs

Share to Tamoxifen

Share to TNF Receptor-Associated Factor 1

Source

Open in PubMed Open full text

Identifiers

PMID: 24699530
DOI: 10.1371/journal.pone.0093420
PMCID: PMC3974759

Genes

TRAF1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24699530-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Integrative "omic" analysis for tamoxifen sensitivity through cell based models.PMID 24699530Read ↗

Genome-wide discovery of genetic variants affecting tamoxifen sensitivity and their clinical and functional validation.Semantic proximity Read ↗

A Genome-Wide Association Study of Endoxifen Serum Concentrations and Adjuvant Tamoxifen Efficacy in Early-Stage Breast Cancer Patients.Semantic proximity Read ↗

An “Omics” Approach to Determine the Mechanisms of Acquired Aromatase Inhibitor ResistanceSemantic proximity Read ↗

EstroGene2.0: A multi-omic database of response to estrogens, ER-modulators, and resistance to endocrine therapies in breast cancerSemantic proximity Read ↗

Model‐Based Quantification of Impact of Genetic Polymorphisms and Co‐Medications on Pharmacokinetics of Tamoxifen and Six Metabolites in Breast CancerSemantic proximity Read ↗

COMBINE: A Comprehensive Multi-Omics Approach for Improving Breast Cancer Prognosis Classification in African American WomenSemantic proximity Read ↗

CYP2D6 Genotype Predicts Plasma Concentrations of Tamoxifen Metabolites in Ethiopian Breast Cancer PatientsSemantic proximity Read ↗

CYP2D6 and Endoxifen in Tamoxifen Therapy: A Tribute to David A. Flockhart.Semantic proximity Read ↗

Personalized medicine in breast cancer: tamoxifen, endoxifen, and CYP2D6 in clinical practice.Semantic proximity Read ↗

Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.Semantic proximity Read ↗

Computational discovery of transcription factors associated with drug response.Semantic proximity Read ↗

Effects of Genetic Polymorphisms of Drug Metabolizing Enzymes and co-Medications on Tamoxifen Metabolism in Black South African Women with Breast Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.